NewAmsterdam Pharma Company N.V.
NAMS
$36.40
-$0.07-0.19%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 56.07% | 57.12% | -453.72% | 57.32% | 58.40% |
| Total Depreciation and Amortization | -13.46% | 1.96% | 82.14% | 47.37% | 26.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 147.54% | -111.73% | 1,431.55% | 1,107.14% | -100.82% |
| Change in Net Operating Assets | -330.34% | 229.71% | -28,600.00% | 100.19% | -43.88% |
| Cash from Operations | -3.30% | 2.70% | -199.80% | 76.84% | 1.14% |
| Capital Expenditure | -450.00% | -433.33% | 96.00% | 64.11% | 45.71% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -5,639.81% | 104.62% | -- | -- | -- |
| Cash from Investing | -5,673.94% | 104.59% | -82,805.33% | 64.11% | 45.71% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -57.74% | -98.23% | 787,203.45% | -98.75% | -97.67% |
| Repurchase of Common Stock | -- | -- | -- | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -6,244.00% | -- | -- | 100.00% |
| Cash from Financing | -47.46% | -98.57% | 787,160.34% | -98.75% | -97.65% |
| Foreign Exchange rate Adjustments | 134.05% | 147.51% | -274.82% | 599.45% | 63.58% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -691.30% | -106.68% | 4,474.16% | 84.18% | -135.85% |